Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients

Lupus

Volumn 18, Issue 9, 2009, Pages 848-855

  Rabbani, M A ^a   Habib, H B ^b   Islam, M ^b   Ahmad, B ^b   Majid, S ^b   Saeed, W ^b   Shah, S M A ^b   Ahmad, A ^a  

^a Kidney Centre Karachi   (Pakistan)

^b AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Lupus; Prognosis; Prognostic indicators; Survival

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ALOPECIA; ARTHRITIS; ARTICLE; CAUCASIAN; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; DISEASE DURATION; DRUG MEGADOSE; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INFECTION; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOUTH ULCER; NEUROLOGIC DISEASE; OVERALL SURVIVAL; PAKISTAN; PLEURA DISEASE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RISK FACTOR; SEIZURE; SEX RATIO; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS RASH;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PAKISTAN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 67650645770     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309103410     Document Type: Article

References (44)

1. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status. Am J Med 1991; 91: 345-353.
2. Merrell M, Shulman LE. Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J ChronicDis 1955; 1: 12-32.
3. Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic Lupus erythematosus. Medicine (Baltimore) 2006; 85: 147-156.
4. Cervera R, KhamashtaMA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003; 82: 299-308.
5. Murali R, Jeyaseelan L, Rajaratnam S, John L, Ganesh A. Systemic lupus erythematosus in Indian patients: Prognosis, survival and life expectancy. Natl Med J India 1997; 10: 159-164.
6. Contreras G, Lenz O, Pardo V, et al. Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 2006; 69: 1846-1851.
7. Gonzalez B, Hernandez P, Olguin H, et al. Changes in the survival of patients with systemic lupus erythematosus in childhood: 30 years experience in Chile. Lupus 2005; 14: 918-923.
8. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 1996; 156: 1337-1344.
9. Panchal L, Divate S, Vaideeswar P, Pandit SP. Cardiovascular involvement in systemic lupus erythematosus: An autopsy study of 27 patients in India. J Postgrad Med 2006; 52: 5-10.
10. Fessler BJ. Infectious diseases in systemic lupus erythematosus: Risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 2002; 16: 281-291.
11. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ,Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 490-492.
12. Murali R, Jeyaseelan L, Rajaratnam S, John L, Ganesh A. Systemic lupus erythematosus in Indian patients: Prognosis, survival and life expectancy. Natl Med J India 1997; 10: 159-164
13. Kasitanon N, Louthrenoo W, Sukitawut W, Vichainun R. Causes of death and prognostic factors in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 2002; 20: 85-91.
14. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
15. Gladman DD, Goldsmith CH, Urowitz MB, et al. Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: International validation. J Rheumatol 1994; 21: 1468-1471.
16. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the systemic lupus international collaborating clinics/ American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
17. Wong KL. Pattern of SLE in Hong Kong Chinese: A cohort study. Scand J Rheumatol 1992; 21: 289-296.
18. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortalitystudies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 1995; 22: 1265-1270.
19. Koh ET, Seow A, Leong KH, Chng HH. Systemic lupus erythematosus mortality in an oriental population. Lupus 1997; 6: 27-31.
20. Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993; 72: 113-124.
21. Gladman DD. Prognosis and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 1996; 8: 430-437.
22. Nossent JC. Systemic lupus erythematosus on the Caribbean Island of Curacao: An epidemiological investigation. Ann Rheum Dis 1992; 51: 1197-1201.
23. Blanco FJ, De la Mata J, Gomez-Reino JJ, et al. Manifestacionesclinicas y serologicas de 307 pacientes espanfoles con lupus eritematososistemico. Comparacion con otros grupos etnicos. Rev Clin Exp 1995; 195: 534-540.
24. Mok CC. Mak, A, Chu,WP, To, CH,Wong, SN. Long-term survival of southern Chinese patients with systemic lupus erythematosus: A prospective study of all age-groups. Medicine (Baltimore) 2005; 84: 218-224.
25. Durán S, Apte M, Alarcón GS; LUMINA Study Group. Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups. J Natl Med Assoc 2007; 99: 1196-1198.
26. Cooper GS, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA. Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 993-999.
27. Bongu A, Chang E, Ramsey-Goldman R. Can morbidity and mortality of SLE be improved. Best Pract Res Clin Rheumatol 2002; 16: 313-332.
28. Rosner S, Ginzler EM, Diamond HS, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of deaths. Arthritis Rheum 1982; 25: 612-617.
29. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: The bimodal pattern revisited.QJMed 1985; 55: 87-98.
30. Esters D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971; 50: 85-95.
31. McLaughlin JR, Bombardier C, Farewell VT, Gladman DD, Urowitz MB. Kidney biopsy in systemic lupus erythematosus: III. Survival analysis controlling for clinical and laboratory variables. Arthritis Rheum 1994; 37: 559-567.
32. Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982; 25: 601-611.
33. Massardo L, Martinez M, Jacobelli S. Survival of Chilean patients with systemic lupus erythematosus. Semin Arthritis Rheum 1994; 24:1-11.
34. Serdula MK, Rhodes GG. Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 1979; 22: 328-333.
35. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus: Identification of racial and socioeconomic influences. Arch Intern Med 1990; 150: 849-853.
36. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 1995; 38: 274-283.
37. Lehman TJA, McCurdy DK, Bernstein BH, King KK, Hanson V. Systemic lupus erythematosus in the first decade of life. Pediatrics 1989; 83: 235-239.
38. Tucker LR, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: A comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995; 44: 866-872.
39. Ho CTK, Mok CC, Lau CS, Wong RWS. Late onset systemic lupus erythematosis in southern Chinese. Ann Rheum Dis 1998; 57: 437-440.
40. Molina JF, Drenkard C, Molina J, et al. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine 1996; 75: 124-130.
41. Miller MH, Urowitz MB, Gladman DD, Killinger DW. Systemic lupus erythematosus in males. Medicine (Baltimore) 1983; 62: 327-334.
42. Mok CC, Lau CS, Chan TM, Wong RWS. Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus. Lupus 1999; 8: 188-196.
43. Stoll T, Seifert B, Isenberg DA. SLICC/ACR damage index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996; 35: 248-254.
44. Korbet SM, Schwartz MM, Evans J, Lewis EJ; Collaborative Study Group. Severe lupus nephritis: Racial differences in presentation and outcome. J Am Soc Nephrol 2007; 18: 244-254.